Analysis of Risk Factors for Revitrectomy in Eyes with Diabetic Vitreous Hemorrhage

Haoxin Guo,1,&ast; Wenbo Li,1,&ast; Kuan Wang,1,2 Zetong Nie,1 Xiang Zhang,1 Siqiong Bai,1 Naxin Duan,1 Xiaorong Li,1 Bojie Hu1 1Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optom...

Full description

Bibliographic Details
Published in:	Diabetes, Metabolic Syndrome and Obesity
Main Authors:	Guo H, Li W, Wang K, Nie Z, Zhang X, Bai S, Duan N, Li X, Hu B
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-09-01
Subjects:	proliferative diabetic retinopathy vitreous hemorrhage revitrectomy fibrinogen retinal ischemia
Online Access:	https://www.dovepress.com/analysis-of-risk-factors-for-revitrectomy-in-eyes-with-diabetic-vitreo-peer-reviewed-fulltext-article-DMSO

Similar Items

Analysis of Risk Factors for Revitrectomy in Eyes with Diabetic Vitreous Hemorrhage [Corrigendum]
by: Guo H, et al.
Published: (2023-10-01)

The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects
by: Cengiz Alagöz, et al.
Published: (2016-10-01)

CLINICAL CHARACTERISTICS OF PROLIFERATIVE DIABETIC RETINOPATHY (PDR) PATIENTS WITH VITREOUS HEMORRHAGE AT CIPTO MANGUNKUSUMO HOSPITAL
by: Reyno Satria Ali, et al.
Published: (2023-02-01)

Study of Etiology of Vitreous Hemorrhage in Adult Patients Attending Tertiary Care Eye Center in Western India
by: Neha Desai, et al.
Published: (2023-04-01)

Intravitreal Bevacizumab (Avastin) in Treatment of Vitreous Hemorrhage due to Proliferative Diabetic Retinopathy
by: Attaullah Shah Bukhari, et al.
Published: (2018-06-01)

Meta-Analysis of risk factors and clinical significance for postoperative vitreous hemorrhage in proliferative diabetic retinopathy
by: Cheng Tang, et al.
Published: (2025-08-01)

Reoperation following vitrectomy for diabetic vitreous hemorrhage with versus without preoperative intravitreal bevacizumab
by: Xuting Hu, et al.
Published: (2019-09-01)

Intravitreal conbercept injection with panretinal photocoagulation for high-risk proliferative diabetic retinopathy with vitreous hemorrhage
by: Yao Xu, et al.
Published: (2024-06-01)

Outcomes of aflibercept for post-vitrectomy vitreous hemorrhage in patients with proliferative diabetic retinopathy
by: O. O. Putienko, et al.
Published: (2021-06-01)

Lipidomic analysis of vitreous humor derived from patients with proliferative diabetic retinopathy
by: Jiawei Wang, et al.
Published: (2025-10-01)

Late postoperative vitreous cavity hemorrhage after vitrectomy for proliferative diabetic retinopathy—observation versus intervention
by: Anand S Brar, et al.
Published: (2024-01-01)

Peripheral Retinal Neovascularization with Vitreous Hemorrhage in HIV Retinopathy
by: Kim Jiramongkolchai, et al.
Published: (2017-06-01)

Causes of vitreous haemorrhage in a tertiary hospital in southern Nigeria
by: Otabor-Olubor OJ, et al.
Published: (2021-01-01)

Factors related to postoperative vitreous hemorrhage after small-gauge vitrectomy in proliferative diabetic retinopathy patients
by: Meng Zhao, et al.
Published: (2023-05-01)

Analysis of risk factors for vitreous hemorrhage and recurrent hemorrhage after vitrectomy in patients with diabetic retinopathy
by: Shuwen Lu, et al.
Published: (2025-05-01)

Results of research of brain-derived neurotrophic factor level (BDNF) in the vitreous body of patients with proliferative diabetic retinopathy
by: A.A. Putienko, et al.
Published: (2016-02-01)

Hypertension as an Unusual Cause of Proliferative Retinopathy: Case Report and Literature Review
by: Rami Hasan Saleem Abu Sbeit, et al.
Published: (2021-07-01)

Comprehensive assessment of growth factors, inflammatory mediators, and cytokines in vitreous from patients with proliferative diabetic retinopathy
by: Qiao-Yun Gong, et al.
Published: (2022-11-01)

The multifaceted role of vitreous hyalocytes: Orchestrating inflammation, angiomodulation and erythrophagocytosis in proliferative diabetic retinopathy
by: Stefaniya K. Boneva, et al.
Published: (2024-11-01)

Characterization of Vitreous Microbiota Dysbiosis Associated with Proliferative Diabetic Retinopathy
by: Song F, et al.
Published: (2025-07-01)

Vitrectomy for diabetic retinopathy: A review of indications, techniques, outcomes, and complications
by: Nimesh C. Patel, et al.
Published: (2024-12-01)

Intravitreal Bevacizumab in Vitreous Hemorrhage and Diabetes Mellitus
by: Beuy Joob, et al.
Published: (2017-03-01)

Proteomic study of vitreous in proliferative diabetic retinopathy patients after treatment with aflibercept: a quantitative analysis based on 4D label-free technique
by: Ting-Ting Feng, et al.
Published: (2024-04-01)

Angiopoietins and prediction of vitreous hemorrhage in type 2 diabetes patients with diabetic retinopathy
by: S. O. Rykov, et al.
Published: (2022-03-01)

Liquid Biopsy for Proliferative Diabetic Retinopathy: Single-Cell Transcriptomics of Human Vitreous Reveals Inflammatory T-Cell Signature
by: Rachana Haliyur, MD, PhD, et al.
Published: (2024-11-01)

Antioxidant Status in the Vitreous of Eyes with Rhegmatogenous Retinal Detachment with and without Proliferative Vitreoretinopathy, Macular Hole and Epiretinal Membrane
by: Agata Pietras-Baczewska, et al.
Published: (2021-05-01)

Treatment of hemorrhagic retinal detachment additionally complicated by vitreous hemorrhage in a patient with end-stage renal failure
by: Mikołaj Guzikowski, et al.
Published: (2025-03-01)

Anatomic and Topographic Vitreous and Vitreoretinal Interface Features in Proliferative Diabetic Vitreoretinopathy
by: N. M. Kislitsyna, et al.
Published: (2020-06-01)

Searching for Biomarkers in Proliferative Diabetic Retinopathy: Amphiregulin and Progranulin
by: Burak BILGIN, et al.
Published: (2022-12-01)

Two cases of severe Purtscher-like retinopathy demonstrating recurrence and progression to neovascularization and vitreous hemorrhage
by: Debora H. Lee, et al.
Published: (2020-06-01)

Association between stress hyperglycemia ratio and diabetic retinopathy progression and surgical prognosis: insights from NHANES 2005–2018 and clinical cohort study
by: Zetong Nie, et al.
Published: (2025-07-01)

Vitrectomy for cases of diabetic retinopathy
by: Nawazish Shaikh, et al.
Published: (2024-12-01)

Study of the correlation between ApoB/ApoA1 and vitreous hemorrhage secondary to diabetic retinopathy
by: Dan Yujiao, Zhang Ling, Chen Bin
Published: (2023-10-01)

Scleral Buckling Versus Primary Vitrectomy in the Management of Retinal Detachment Associated with Mild Vitreous Hemorrhage
by: Tansu Erakgün, et al.
Published: (2014-03-01)

Temporal association of vitreous hemorrhage and hypertension after COVID‐19 mRNA vaccines
by: Toshihiko Matsuo, et al.
Published: (2022-11-01)

Metabolic Deficiencies in the Vitreous of Diabetic Retinopathy: Exploring the Potential of Dietary Supplementation to Address Key Metabolite Imbalances
by: Hiller JK, et al.
Published: (2025-08-01)

Correlation Between Vitreous Advanced Glycation End Products, and D-dimer with Blood HbA1c Levels in Proliferative Diabetic Retinopathy
by: Tonny Loho, et al.
Published: (2018-06-01)

Correlation Between Vitreous Advanced Glycation End Products, and D-dimer with Blood HbA1c Levels in Proliferative Diabetic Retinopathy
by: Tonny Loho, et al.
Published: (2018-06-01)

Vitrectomy Due to Vitreous Hemorrhage and Tractional Retinal Detachment Secondary to Eales’ Disease
by: M. Giray Ersöz, et al.
Published: (2021-04-01)

Prophylactic intravitreal injection of aflibercept for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy: A randomized controlled trial
by: Jinfeng Qu, et al.
Published: (2023-01-01)